% | $
Quotes you view appear here for quick access.

Seattle Genetics, Inc. Message Board

koolbrez22 136 posts  |  Last Activity: 1 hour 1 minute ago Member since: Jan 21, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    150 million share float

    by bmcgoo_03 5 hours ago
    koolbrez22 koolbrez22 1 hour 1 minute ago Flag

    The planning part is way overboard. If Al and Matt were brainy enough to think of planning anything, we would not have been diluted below a $1. Al was good at envisioning things technical but when it came to running a business he just got lucky a couple times then when it came to MNKD his luck ran out and the people that he surrounded himself with (Matt, Hakan) are neither lucky nor smart. Hence we are trading below a buck and Afrezza still has not launched 2 years after FDA approval.

  • Reply to

    150 million share float

    by bmcgoo_03 5 hours ago
    koolbrez22 koolbrez22 1 hour 9 minutes ago Flag

    Totally reasonable contention. Unfortunately it willnot come back to haunt them because the haunted are always the shareholders. Heads they win and tails we lose.

  • Reply to


    by congomunro 17 hours ago
    koolbrez22 koolbrez22 6 hours ago Flag

    Highly doubt that it's the work of only one individual. This is the work of a team posing as one person and the reason that whomever id behind this effort keeps it up is because there are enough weak minded people that allow themselves of being persuaded to separate with their shares at a very low price. I use my ignore button as needed and I can see that 90 percent of the posts are from irrelevant entities and 90 percent of them are from this one supposed individual. Not buying it and if it is so important for some organization to put up such an effort, then there must be the same value on the opposite side of where they're at. I like the odds going forward. If Mr Castagna can bring it home by surpassing SNY high water mark for script count (~ 620) by labor day, then we will have a real race going and funding the operation beyond Q4 will get a whole lot easier even for Matt.

  • Reply to

    MNKD and Sanofi

    by chuck3325 May 25, 2016 6:59 AM
    koolbrez22 koolbrez22 May 25, 2016 7:07 AM Flag

    Please not again.
    As far as MNKD is concerned, SNY is deader than Elvis.
    Gone, done finito. May they RIP.

  • koolbrez22 koolbrez22 May 24, 2016 9:25 PM Flag

    Hopefully Rumsfeld is not running MNKD. There are enough challenges as it is without additional complications. We are already going to market with the sales team that we can put together rather than the one that we wish we had just paraphrasing Rummy again.

  • Reply to

    When will 2.0 sales force engage?

    by rileysmith0144 May 24, 2016 2:19 AM
    koolbrez22 koolbrez22 May 24, 2016 6:57 AM Flag

    Totally unsettling if true. Why would it take more than a few days since most of the hires came from AZ and are already experienced in the diabetes field? If it takes weeks to learn how to use the inhaler so that they can demonstrate to others, then we are really screwed.

  • Reply to

    Bakers not buying!

    by bullsrunsoon May 20, 2016 10:53 PM
    koolbrez22 koolbrez22 May 20, 2016 11:18 PM Flag

    Not to worry. Madame Yellen or crooked Hellery will soon make a statement to fix that biotech rally.
    Seriously though, I'd give it another couple of days to makesure but looks really good if it holds.

  • Reply to

    Elephant in the room.

    by surplus.value May 19, 2016 9:10 PM
    koolbrez22 koolbrez22 May 20, 2016 7:07 AM Flag

    They are not ignoring it, they just can't do any better under the circumstances. Note that they had to give away circa 12 percent of the company for the measly $ 46 millions they raised and an additional equal amount in future warrants ( sounds like a typical Deerfield deal).
    Unless you are from the IRS, you can't get blood from a stone and they can't get more money than they got if people are not willing to lend it to them. The terms of the deal appear to be like a gradual lending program where the initial $46 M is enough to get things started and by the time that they run out of cash, the lender will be able to assess the probability of success. If things look promising by then, they will exercise the warrants and add about $70 million more to the effort. Obviously the lender thinks that $ 120-150 million is what is needed to achieve breakeven. If things fail the lender loses the original 50 but if it works thay will own 25 percent of the company by then potentially valued at at least 10x their investment.
    That's it in a nutshell.
    Btw I'm not a divinity guy by any stretch. Just a figure of speech.

  • Reply to

    Elephant in the room.

    by surplus.value May 19, 2016 9:10 PM
    koolbrez22 koolbrez22 May 19, 2016 10:13 PM Flag

    Since the host has no credibility left, why would his answers to any questions mean anything?
    At this point the only hope left is that the new guy driving the commercialization bus knows what he is doing and gets it done fast. Other than that, the only alternative is divine intervention.

  • koolbrez22 koolbrez22 May 19, 2016 10:02 PM Flag

    Are you arguing with our thoughts being in agreement?

  • koolbrez22 koolbrez22 May 19, 2016 9:59 PM Flag

    Actually they all sound the same to me but point well taken

  • Reply to

    Bakers must be buying

    by bullsrunsoon May 17, 2016 4:19 PM
    koolbrez22 koolbrez22 May 19, 2016 9:55 PM Flag

    Hopefully they won't. SGEN has been range bound for two years and a breakout should be imminent. If The price spike is once again due to BB buying then it will sink back to low 30's. Surely it is circumstantial but it has been clockwork that as soon as the biotech index has an couple of good days the Fed crash the market. I'm almost impatient for the day that president Trump fires the ugly windbag.

  • Reply to

    Anyone in Danbury . . .

    by nomdguer May 19, 2016 12:23 PM
    koolbrez22 koolbrez22 May 19, 2016 9:46 PM Flag

    Given the financials, increasing burn out to pursue EU approval would be foolish at this time. I'd say that they are correct to focus on the here and now in the US and worry about foreign approval after survival is secured in the US market which is a big enough market for the purposes. That's the price for succumbing to SNY's trojan horse.

  • koolbrez22 koolbrez22 May 19, 2016 9:33 PM Flag

    If the guy is serious, I don't see a reason why they can't get started by buying at least 4.9 percent of the share in the open market since the shares are highly discounted and then take the offer to the struggling shareholders. Either the guy is a shill or they are looking to buy shares at 10 cents. It's not like that buying 25 million shares on the open Market is going to jack up the price by more than $ 0.50 which is arguably the bargain of the century if they can get Afrezza approved in China. Given the situation they can probably buy 25 percent of MNKD without spiking the price above $2. If the Chinese bank had serious intent, they could easily amass ownership rivaling Mann's groups and be able to do to MNKD's BOD what Mr Trump has done to the Republican establishment.

  • koolbrez22 koolbrez22 May 19, 2016 9:20 PM Flag

    If you had not behaved so cynically forever and a day I'd be inclined to side with that thought of yours given all the lying by Matt over the past couple of years.
    If it were to be true though, it could be the spark needed to get the Afrezza fire really going. About half of the world's PWD live in China and India so if it were to be adopted at least in one of these markets, even at a discount, Afrezza would be a gold mine. The chances of the guy being a plant are about 50/50 but even whith those odds the prospects are north of where we were left as road kill by SNY's betrail and disparagement. I'm greatly encouraged by the new guy's confidence to put his money on the line. If things begin to spin as we hope they may, it won't be long before the new guy becomesCEO and Matt joins Hakan on the bone pile.

  • koolbrez22 koolbrez22 May 19, 2016 9:04 PM Flag

    Hey Kev,
    If you want to be taken seriously then at least spell people's names right. Messing up names makes you sound disjointed and aloof. The guy's name is Castagna not Castaglia. Surely you can make the difference between "n" and "li" unless you are dislexic.

  • Reply to


    by trazodone.freak May 15, 2016 7:39 PM
    koolbrez22 koolbrez22 May 15, 2016 8:59 PM Flag

    Guess you are not one of those int the know then. Had you been so you would have known that the "Italians" as you put it are way more enterprising to have only one of those organizations. Cosa nostra are sicilians, but calabresi and napoletans would not be part of a sicilian organization and each have their own. If you want to find out what they call it, go do DD.

  • koolbrez22 koolbrez22 May 15, 2016 8:52 PM Flag

    And that type of pricing was most damaging to script count more than the lack of marketing because why the lack of advertsing keapt Afrezza unknown to the masses of PWD the predatory pricing keapt even the few that became aware of Afrezza and got their Dr. To script it by their own research or by chance from renewing their scripts even if their insurance carrier had it covered as a tier 3. It really angers me that 6 months after the SNY drop, MNKD is still not moving heaven and earth to at least lower the price.

  • Reply to

    Interesting 8-K filed today...

    by mslans May 13, 2016 4:58 PM
    koolbrez22 koolbrez22 May 14, 2016 9:45 AM Flag

    Not to overstate things but the part about vesting on acquisition is likely an aknowledgment that there is expectation that an acquisition before/around P3 results will be consumated. That in itself is a good indicator that BOD is already negotiating on the subject. Given that SGEN shares are currently heavily discounted due to generally poor market conditions for bios, unless we see some new buying from BB in the near future, a deal is most likely to happen between Q4 '16 and mid '17.
    My wag on it is that the price will be $ 15 billions +/- a couple.

  • koolbrez22 koolbrez22 May 12, 2016 7:15 AM Flag

    One needs to be numb not to know we're at the brink. However Matt is still operating the same way he did prior which got us here. He scoffed at the idea of dilution every time it was clearly a necessity to do so only to reverse himself later after the SP had collapsed due to the uncertainety about the company's financial viability. A CFO worth his salt knows how to fund the company at the time that minimizes the dilution and not to wait until the brink when dilution is maximized. He has done it wrongly so many times to the point where he is void of any credibility which is now another aggravating factor that adds to the maximization of dilution.
    Why else do you think that we were just diluted at a 40 percent discount to the SP at the time of dilution?
    Matt is costing us a bundle just by being in charge. Compare to it, his salary, bonus and stock options, although being rich for the performance is chump change compared to the destruction of value that his association to the company brings about. He should have been fired as CFO even before Hakan was.

40.24+0.65(+1.64%)4:00 PMEDT